Portal de Periódicos da CAPES

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies

2001; Wiley; Volume: 186; Issue: 1 Linguagem: Inglês

10.1002/1097-4652(200101)186

1097-4652

Marc F. D Cristofaro, Bryan L. Betz, Checo J. Rorie, David Reisman, Weidong Wang, Bernard E. Weissman,

Genomic variations and chromosomal abnormalities

Organization of genomic DNA into chromatin aids in the regulation of gene expression by limiting access to transcriptional machinery. The SWI/SNF family of complexes, which are conserved from yeast to humans, are ATP-dependent chromatin-remodeling enzymes required for the transcription of a number of genes in yeast. In humans, the gene encoding the BAF47/hSNF5 subunit of the complex, located at 22q11.2, has been found to be mutated in a number of human tumors including rhabdoid, rhabdomyosarcoma, chronic myeloid leukemia, and CNS tumors such as medulloblastomas and choroid plexus carcinomas. In addition, loss of heterozygosity (LOH) has been reported for the BAF47 region in breast and liver cancer. LOH has also been reported in breast and ovarian cancer within 17q12-25, a gene-rich area including BRCA1, BAF60B, and BAF57. Interestingly, the gene encoding the BAF155/hSWI3 subunit of the complex maps to 3p21-p23, an area of chromosomal deletion seen in a number of human adenoca rcinomas including breast, kidney, pancreas, and ovary. To look for abnor malities in these proteins as well as the SWI/SNF complex in general, we have determined the protein status of core human SWI/SNF components BAF170, BAF155, BAF57, BAF53a, and BAF47 in 21 breast cell lines. The complex status in other human tumor cell lines of various tissue types was also examined. We also determined the protein status of the human SWI2 homologues, hBRM/SWI2α and BRG1/SWI2β as well as two other proteins found in human SWI/SNF complexes, BAF180 and BAF250. In this study, we identified the first cell line negative for the BAF57 protein as well as a pancreatic carcinoma cell line negative for both the BRG-1 and hBRM proteins. J. Cell. Physiol. 186:136–145, 2001. © 2001 Wiley-Liss, Inc.